LibraGen launches first family of active products obtained by biocatalysis
French company LibraGen, of Toulouse, has launched its first family of active products obtained through a patented enzymatic process.
French company LibraGen, of Toulouse, has launched its first family of active products obtained through a patented enzymatic process.
This marks a significant step forward for LibraGen as an industry player in its own right for the design and production by biocatalysis of innovative high value-added molecules.
Using its proprietary technology platform, LibraGen has designed an exclusive enzymatic production process to allow the use of naturally derived active molecules that have hitherto proved difficult to exploit because of their physical and chemical properties.
This process transforms the raw materials into water-soluble active molecules, which are chemically more stable and have an improved biological availability. This first series of compounds covers a wide and diverse range of biological structures and activities belonging to the polyphenols family.
'The market availability of this first collection of pioneering products is the result of LibraGen's know-how in the development of new enzymatic reactions and the implementation of biocatalytic production processes,' said Renaud Nalin, ceo at LibraGen. 'This new range gives a glimpse of the potential we have with our technology and production capabilities as they are all applicable to other active ingredients.'
